Concorde Financial’s Lam Research LRCX Stock Holding History

Concorde Financial’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-60	Closed	-$4K	–	100
2021 Q4	$4K	Buy	+60	New	+$3.76K	﹤0.01%	117

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Concorde Financial's LRCX Position: Q1 2022 in Review

Concorde Financial sold out of Lam Research (LRCX) in Q1 2022, closing a stake of 60 shares — an estimated $4K sold.

Concorde Financial first reported a position in LRCX in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 1,389 funds tracked by Wall St. Rank hold LRCX as of Q1 2022.

Concorde Financial reported no remaining Lam Research position as of Q1 2022 after selling out during the quarter.
Concorde Financial sold 60 Lam Research shares in Q1 2022, an estimated $4K.
Concorde Financial first reported a position in Lam Research in Q4 2021 and held it in 1 quarter.
Concorde Financial's Lam Research position peaked at $4K in Q4 2021.
1,389 funds tracked by Wall St. Rank held Lam Research as of Q1 2022.

Based on Concorde Financial's 13F filing for Q1 2022, filed 16 May 2022.